Detalhe da pesquisa
1.
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age.
N Engl J Med
; 388(7): 621-634, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791162
2.
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Clin Infect Dis
; 74(8): 1459-1467, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283213
3.
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
J Pediatric Infect Dis Soc
; 12(4): 234-238, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36929216
4.
Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study.
Hum Vaccin Immunother
; 18(1): 1-10, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085900